# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001144204-16-087376
Filing Date
2016-03-11
Accepted
2016-03-11 09:00:23
Documents
51
Period of Report
2016-03-11
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 8-K | v434047_8-k.htm | 8-K | 15284
2 | EXHIBIT 99.1 | v434047_ex99-1.htm | EX-99.1 | 29046
3 | EXHIBIT 99.2 | v434047_ex99-2.htm | EX-99.2 | 23620
4 | GRAPHIC | ex99-2_01.jpg | GRAPHIC | 33739
5 | GRAPHIC | ex99-2_02.jpg | GRAPHIC | 163121
6 | GRAPHIC | ex99-2_03.jpg | GRAPHIC | 63972
7 | GRAPHIC | ex99-2_04.jpg | GRAPHIC | 75932
8 | GRAPHIC | ex99-2_05.jpg | GRAPHIC | 85646
9 | GRAPHIC | ex99-2_06.jpg | GRAPHIC | 66404
10 | GRAPHIC | ex99-2_07.jpg | GRAPHIC | 70126
11 | GRAPHIC | ex99-2_08.jpg | GRAPHIC | 76867
12 | GRAPHIC | ex99-2_09.jpg | GRAPHIC | 84887
13 | GRAPHIC | ex99-2_10.jpg | GRAPHIC | 80438
14 | GRAPHIC | ex99-2_11.jpg | GRAPHIC | 93148
15 | GRAPHIC | ex99-2_12.jpg | GRAPHIC | 90918
16 | GRAPHIC | ex99-2_13.jpg | GRAPHIC | 76495
17 | GRAPHIC | ex99-2_14.jpg | GRAPHIC | 72082
18 | GRAPHIC | ex99-2_15.jpg | GRAPHIC | 99987
19 | GRAPHIC | ex99-2_16.jpg | GRAPHIC | 88977
20 | GRAPHIC | ex99-2_17.jpg | GRAPHIC | 67098
21 | GRAPHIC | ex99-2_18.jpg | GRAPHIC | 59845
22 | GRAPHIC | ex99-2_19.jpg | GRAPHIC | 55439
23 | GRAPHIC | ex99-2_20.jpg | GRAPHIC | 62967
24 | GRAPHIC | ex99-2_21.jpg | GRAPHIC | 64000
25 | GRAPHIC | page01.jpg | GRAPHIC | 30871
26 | GRAPHIC | page02.jpg | GRAPHIC | 162994
27 | GRAPHIC | page03.jpg | GRAPHIC | 63726
28 | GRAPHIC | page04.jpg | GRAPHIC | 75932
29 | GRAPHIC | page05.jpg | GRAPHIC | 85847
30 | GRAPHIC | page06.jpg | GRAPHIC | 66503
31 | GRAPHIC | page07.jpg | GRAPHIC | 60508
32 | GRAPHIC | page08.jpg | GRAPHIC | 69923
33 | GRAPHIC | page09.jpg | GRAPHIC | 76498
34 | GRAPHIC | page10.jpg | GRAPHIC | 84909
35 | GRAPHIC | page11.jpg | GRAPHIC | 80494
36 | GRAPHIC | page12.jpg | GRAPHIC | 83571
37 | GRAPHIC | page13.jpg | GRAPHIC | 93088
38 | GRAPHIC | page14.jpg | GRAPHIC | 90982
39 | GRAPHIC | page15.jpg | GRAPHIC | 70887
40 | GRAPHIC | page16.jpg | GRAPHIC | 58806
41 | GRAPHIC | page17.jpg | GRAPHIC | 76513
42 | GRAPHIC | page18.jpg | GRAPHIC | 71832
43 | GRAPHIC | page19.jpg | GRAPHIC | 84571
44 | GRAPHIC | page20.jpg | GRAPHIC | 102008
45 | GRAPHIC | page21.jpg | GRAPHIC | 88716
46 | GRAPHIC | page22.jpg | GRAPHIC | 67087
47 | GRAPHIC | page23.jpg | GRAPHIC | 108960
48 | GRAPHIC | page24.jpg | GRAPHIC | 55582
49 | GRAPHIC | page25.jpg | GRAPHIC | 63392
50 | GRAPHIC | page26.jpg | GRAPHIC | 63779
51 | GRAPHIC | logo.jpg | GRAPHIC | 5687
| Complete submission text file | 0001144204-16-087376.txt |  | 5126997

Mailing Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108
Business Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108 801 994 7383
Lipocine Inc. (Filer) CIK: 0001535955 (see all company filings)

EIN.: 990370688 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36357 | Film No.: 161499485
SIC: 2834 Pharmaceutical Preparations